WallStreetZenWallStreetZen

NYSE: NVO
Novo Nordisk A S Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NVO

Based on 6 analysts offering 12 month price targets for Novo Nordisk A S.
Min Forecast
$115.00-7.65%
Avg Forecast
$133.00+6.8%
Max Forecast
$163.00+30.89%

Should I buy or sell NVO stock?

Based on 6 analysts offering ratings for Novo Nordisk A S.
Strong Buy
Strong Buy
4 analysts 66.67%
Buy
2 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NVO stock forecasts and price targets.

NVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-12
lockedlocked$00.00+00.00%2024-04-05
lockedlocked$00.00+00.00%2024-02-01
lockedlocked$00.00+00.00%2024-01-23
lockedlocked$00.00+00.00%2023-12-04
Argus Research
Top 6%
95
Strong BuyMaintains$115.00-7.65%2023-12-01

1 of 1

Forecast return on equity

Is NVO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is NVO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NVO revenue forecast

What is NVO's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$42.0B+22.07%
Avg 2 year Forecast
$51.9B+50.75%
Avg 3 year Forecast
$59.4B+72.74%
NVO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NVO earnings growth forecast

How is NVO forecast to perform vs Biotechnology companies and vs the US market?
Company
4.76%
Industry
7.3%
Market
21.75%
NVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NVO revenue growth forecast

How is NVO forecast to perform vs Biotechnology companies and vs the US market?
Company
21.03%
Industry
38.32%
Market
10.27%
NVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NVO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NVO$124.53$133.00+6.80%Strong Buy
VRTX$393.10$450.86+14.69%Buy
REGN$901.19$996.20+10.54%Buy
MRNA$103.44$127.14+22.91%Buy
ARGX$366.20$511.00+39.54%Strong Buy
View Top Biotech Stocks

Novo Nordisk A S Stock Forecast FAQ

Is Novo Nordisk A S Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: NVO) stock is to Strong Buy NVO stock.

Out of 6 analysts, 4 (66.67%) are recommending NVO as a Strong Buy, 2 (33.33%) are recommending NVO as a Buy, 0 (0%) are recommending NVO as a Hold, 0 (0%) are recommending NVO as a Sell, and 0 (0%) are recommending NVO as a Strong Sell.

If you're new to stock investing, here's how to buy Novo Nordisk A S stock.

What is NVO's revenue growth forecast for 2024-2026?

(NYSE: NVO) Novo Nordisk A S's forecast annual revenue growth rate of 21.03% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Novo Nordisk A S's revenue in 2024 is $33,808,005,822.On average, 2 Wall Street analysts forecast NVO's revenue for 2024 to be $189,438,049,020,000, with the lowest NVO revenue forecast at $184,732,351,100,000, and the highest NVO revenue forecast at $194,143,751,450,000. On average, 3 Wall Street analysts forecast NVO's revenue for 2025 to be $233,934,583,960,000, with the lowest NVO revenue forecast at $228,680,632,400,000, and the highest NVO revenue forecast at $236,609,798,700,000.

In 2026, NVO is forecast to generate $268,067,833,440,000 in revenue, with the lowest revenue forecast at $260,647,061,400,000 and the highest revenue forecast at $275,488,605,480,000.

What is NVO's forecast return on assets (ROA) for 2024-2027?

(NYSE: NVO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NVO's Price Target?

According to 6 Wall Street analysts that have issued a 1 year NVO price target, the average NVO price target is $133.00, with the highest NVO stock price forecast at $163.00 and the lowest NVO stock price forecast at $115.00.

On average, Wall Street analysts predict that Novo Nordisk A S's share price could reach $133.00 by Apr 12, 2025. The average Novo Nordisk A S stock price prediction forecasts a potential upside of 6.8% from the current NVO share price of $124.53.

What is NVO's forecast return on equity (ROE) for 2024-2027?

(NYSE: NVO) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.